Echo Therapeutics (ECTE) Posts Wider than Expected Q1 Loss of 8c/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Interest expense: -133.06K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest expense: -133.06K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $30.93 thousand versus the consensus estimate of $80 thousand.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
